Reset Map9 Results
209 Fairfield Rd Fairfield, NJ, 07004 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
3131 N Vancouver Ave Portland, OR, 97227 1560 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
1955 Monroe Dr NE Atlanta, GA, 30324 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
180 Rustcraft RD Dedham, MA, 02026 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
3150 E 29th St Long Beach, CA, 90806 2319 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
700 Spring Garden St Philadelphia, PA, 19123 3508 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
337 Stoneridge Ln Columbus, OH, 43230 6783 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
430 17th St NW Washington, District of Columbia, 20006 5307 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
520 West 49th Street New York, NY, 10019 United StatesAmerican Red Cross Cell and Gene Therapy Solutions has been a trusted partner to the cell and gene therapy industry for over a decade, backed by 30+ years of apheresis collections experience and 75+ years of donor management expertise. Our centrally managed collection network operates under a single National Quality Management System (QMS), standardizing procedures across all sites to improve consistency in starting material across collections. Collections are performed by trained Red Cross employees from IRB-consented, pre-screened healthy donors. Customizable donor selection, including age, BMI, ethnicity, and HLA and KIR typing, combined with strong donor recallability and dedicated donor pools, ensures your sourcing requirements are met at every stage. Whether you need GMP or RUO grade material, our leukopaks are available fresh or cryopreserved, in a range of collection sizes to fit your research needs, available as whole leukopak products or processed into PBMCs/MNCs with optional characterization from our five cell therapy labs to support downstream workflows: - CBC with 5-part differential - CD34+ with 7-AAD viability - TBNK immunophenotyping Real-time blood product testing within 30 minutes post-collection, providing rapid immunophenotyping and viability results without the delays of central lab processing. Fresh leukopaks are collected across seven centers nationwide, supporting same-day delivery in multiple geographies, while cryopreserved options offer greater scheduling flexibility and reduced lead time. For early-stage research and process development, buffy coats provide a cost-effective leukocyte source. With access to a large pool of recallable donors, the Red Cross is well positioned to support programs from early discovery through commercialization, enabling consistency across collections as your program scales. Ask us about commitment-based pricing designed to support predictable supply and operational efficiency.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.